AEVS 📈 Aevis Victoria SA - Overview

Exchange: SW • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0478634105

AEVS: Healthcare, Hospitality, Real Estate, Telemedicine, Ambulance, Radiology, Pharmacy

Aevis Victoria SA engages in healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. The company operates through Hospitals, Hospitality, Real Estate, and Others segments. It also provides telemedicine, ambulance, life sciences related services, patient hotel, radiology institute, pharmacy, ophthalmology, medical radiation, stem cells, cosmetics, parking, cleaning services, sterilization, and IT related services. In addition, the company operates urology center, health center, day clinics, and golf courses. The company is headquartered in Fribourg, Switzerland. Aevis Victoria SA is a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A. Web URL: https://www.aevis.com

Additional Sources for AEVS Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

AEVS Stock Overview

Market Cap in USD 1,333m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception

AEVS Stock Ratings

Growth 5y 8.84%
Fundamental -4.51%
Dividend 14.9%
Rel. Strength Industry -878
Analysts -
Fair Price Momentum 12.88 CHF
Fair Price DCF -

AEVS Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 65.0%

AEVS Growth Ratios

Growth Correlation 3m -23.3%
Growth Correlation 12m -84.5%
Growth Correlation 5y 66%
CAGR 5y 0.80%
CAGR/Mean DD 5y 0.05
Sharpe Ratio 12m -0.92
Alpha -29.17
Beta 0.27
Volatility 37.63%
Current Volume 9k
Average Volume 20d 6.5k
What is the price of AEVS stocks?
As of December 21, 2024, the stock is trading at CHF 13.70 with a total of 8,997 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +0.00%, over three months by +1.45% and over the past year by -18.13%.
Is Aevis Victoria SA a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Aevis Victoria SA is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -4.51 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AEVS as of December 2024 is 12.88. This means that AEVS is currently overvalued and has a potential downside of -5.99%.
Is AEVS a buy, sell or hold?
Aevis Victoria SA has no consensus analysts rating.
What are the forecast for AEVS stock price target?
According to ValueRays Forecast Model, AEVS Aevis Victoria SA will be worth about 13.9 in December 2025. The stock is currently trading at 13.70. This means that the stock has a potential upside of +1.53%.
Issuer Forecast Upside
Wallstreet Target Price 15 9.5%
Analysts Target Price - -
ValueRay Target Price 13.9 1.5%